Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/BRIVIACT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

BRIVIACT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Ucb Pharma🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 31, 2024
Approval ID: 2cd308c8d8a348fa
Company: Ucb Pharma
Type: Standard

Approval Details

Approval Id: 2cd308c8d8a348fa
Drug Cima Aemps Name: BRIVIACT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 151073018IP2
Holder Company Name: Ucb Pharma
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/ucb-pharma-sa
Authorization Date: 2024-07-31
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 100 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Ucb Pharma
Company Detail Path: /organization/ucb-pharma-sa

Company Information

Pharmaceutical Company Name: UCB S.A.
Name En: UCB S.A.
Country Name: Belgium
City Name: Brussels
Address: Brussels, Belgium
Website: https://www.ucb.com

Active Ingredients

BRIVARACETAM

100 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 31, 2024

Approval ID

2cd308c8d8a348fa

Type

Standard

Back to CIMA-AEMPS Approvals

BRIVIACT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details